12 new drugs are forecast to enter the market in 2018 and achieve blockbuster sales of USD1 billion or more by 2022
Programme aims to equip working professionals in healthcare, biomedical, and policy makers, with updated scientific and regulatory knowledge and critical skills through application-based learning.
New Tissue Engineering Project House established in Singapore, focuses on specialty materials for health and medical applications.
Investment marks an important milestone for Singapore's MedTech startup scene
AdAlta's lead drug for treatment of Idiopathic Pulmonary (lung) Fibrosis AD-114 redesigned as new molecule, called AD-214.
Disruptive technologies can add value to personalised treatments for patients, says GlobalData.
There are differences in the availability of orphan medicines between different European countries, a new study from the University of Eastern Finland shows.